TRPV1 and Waldenstrom macroglobulinemia: Furthermore, with the nine under-treatment and three de novo MM patients, TRPV1 expression was found to be similar (n = 10) or increased (n = 2, a de novo with lambda, B-2-microglobulinimia, and an under-treatment patient with Waldenstrom macroglobulinemia) compared to controls (Table S3).